<p>Surrozen, Inc.（纳斯达克代码：SRZN - 获取免费报告）主要股东 Group Gp Lp Column III 于 1 月 14 日星期三收购了 5,523 股该公司的股票。每股平均购买价格为 19.99 美元，总交易额为 110,404.77 美元。交易完成后，该内部人士直接持有公司 999,429 股股票，价值 19,978,585.71 美元。此次交易使其持股增加了 0.56%。该购买在向证券交易委员会的法律文件中披露，相关信息可通过此链接获取。持有公司超过 10% 股份的大股东需向 SEC 披露其买卖情况。</p>
<p>Group Gp Lp Column III 最近还进行了以下交易：</p>
<ul>
<li>在 1 月 13 日星期二，Group Gp Lp Column III 购买了 12,470 股 Surrozen 股票。每股平均购买价格为 19.80 美元，总价值为 246,906.00 美元。</li>
<li>在 1 月 6 日星期二，Group Gp Lp Column III 购买了 15,100 股 Surrozen 股票。每股平均价格为 19.89 美元，总交易额为 300,339.00 美元。</li>
<li>在 12 月 5 日星期五，Group Gp Lp Column III 购买了 30,884 股 Surrozen 股票。每股平均价格为 19.54 美元，总交易额为 603,473.36 美元。</li>
<li>在 12 月 4 日星期四，Group Gp Lp Column III 购买了 5,266 股 Surrozen 股票。每股平均购买价格为 17.35 美元，总价值为 91,365.10 美元。</li>
<li>在 11 月 13 日星期四，Group Gp Lp Column III 收购了 315,457 股 Surrozen 股票。每股平均价格为 12.65 美元，总价值为 3,990,531.05 美元。</li>
</ul>
<h2>Surrozen 股票表现</h2>
<p>SRZN 股票在星期四的午盘交易中保持在 20.00 美元。该公司的交易量为 28,721 股，而其平均交易量为 83,852 股。该公司的 50 日简单移动平均线为 18.38 美元，200 日简单移动平均线为 13.80 美元。Surrozen, Inc.的 52 周最低价为 5.90 美元，52 周最高价为 24.94 美元。该股票的市值为 1.714 亿美元，市盈率为-0.90，贝塔值为 0.58。</p>
<p>Surrozen（纳斯达克代码：SRZN - 获取免费报告）最近于 11 月 7 日星期五发布了其财报。该公司报告本季度每股收益为（3.61 美元），低于分析师一致预期的（1.17 美元），差距为（2.44 美元）。该季度的收入为 98 万美元。Surrozen 的股本回报率为-4,055.04%，净利润率为-2,909.10%。分析师平均预测 Surrozen, Inc.在本年度的每股收益为-8.49 美元。</p>
<h2>分析师设定新目标价</h2>
<p>几家研究公司对 SRZN 发布了报告。Lifesci Capital 在 11 月 13 日的研究报告中将 Surrozen 的股票评级上调至 “强力买入”。Weiss Ratings 在 10 月 8 日的报告中重新发布了 Surrozen 的 “卖出（d-）” 评级。最后，Wall Street Zen 在 11 月 28 日的研究报告中将 Surrozen 的股票评级上调至 “卖出”。一位投资分析师给予该股票 “强力买入” 评级，一位给予 “买入” 评级，一位给予 “卖出” 评级。根据 MarketBeat.com 的数据，该公司目前的平均评级为 “适度买入”，共识目标价为 32.00 美元。</p>
<p><strong>查看我们对 SRZN 的最新分析</strong></p>
<h2>机构投资者对 Surrozen 的看法</h2>
<p>对冲基金和其他机构投资者最近对该公司的持仓进行了调整。Braidwell LP 在第二季度购买了 Surrozen 的新头寸，价值约为 1,252,000 美元。Stempoint Capital LP 在第二季度将其在 Surrozen 的持股增加了 185.1%。Stempoint Capital LP 现在拥有 686,539 股该公司股票，价值 6,138,000 美元，此前在上个季度又购买了 445,713 股。Stonepine Capital Management LLC 在第二季度将其在 Surrozen 的持股增加了 7.1%。Stonepine Capital Management LLC 现在拥有 306,029 股该公司股票，价值 2,736,000 美元，此前在上个季度又购买了 20,247 股。Vanguard Group Inc.在第三季度将其在 Surrozen 的持仓增加了 21.7%。Vanguard Group Inc.现在拥有 266,418 股该公司股票，价值 3,433,000 美元，此前在该期间又收购了 47,468 股。最后，Acuta Capital Partners LLC 在第三季度将其在 Surrozen 的持股增加了 5.0%。Acuta Capital Partners LLC 现在拥有 178,415 股该公司股票，价值 2,299,000 美元，此前在上个季度又收购了 8,415 股。对冲基金和其他机构投资者持有该公司 66.57% 的股份。</p>
<h2>Surrozen 公司简介</h2>
<p>（获取免费报告）</p>
<p>Surrozen, Inc 是一家临床阶段的生物制药公司，专注于开发针对 Wnt 信号通路的新型治疗性抗体，应用于组织修复、再生和肿瘤学。该公司成立于 2012 年，总部位于加利福尼亚州南旧金山，利用其专有的 SurroBody 平台设计双特异性抗体分子，能够调节 Wnt 受体活性，具有增强的组织特异性。</p>
<p>SurroBody 平台能够生成高亲和力、双结合抗体，这些抗体经过工程设计，能够激活或抑制 Wnt 信号通路，而该通路对细胞增殖、分化和稳态至关重要。</p>
<h2>进一步阅读</h2>
<ul>
<li>我们更看好的五只股票比 Surrozen 更好</li>
<li>Elon 将 SpaceX 上市！$100 的首次公开募股机会！</li>
<li>家族信托如何帮助保护您的财富</li>
<li>一项价值数万亿的美国 “出生权” 索赔 - 静悄悄地激活</li>
<li>执行命令 14330：特朗普最大的一次</li>
<li>崩盘已经开始（大多数人只是还没看到）</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/InsiderTradesChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9U1JaTg?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/InsiderTradesChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9U1JaTg"/></p>
<p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，旨在为读者提供最快的报道和公正的覆盖。请将有关此故事的任何问题或评论发送至 contact@marketbeat.com.</em></p>
<h2>你现在应该投资 1,000 美元在 Surrozen 吗？</h2>
<p>在考虑 Surrozen 之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只股票，顶级分析师正在悄悄地向客户推荐在更广泛的市场注意到之前购买……而 Surrozen 并不在名单上。</p>
<p>虽然 Surrozen 目前在分析师中获得了中等买入评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

SRZN

<p>Surrozen, Inc.（纳斯达克代码：SRZN）主要股东 Group Gp Lp Column III 以每股 19.99 美元的价格购买了 5,523 股，总计 110,404.77 美元，增持了 0.56% 的股份。交易后，他们持有 999,429 股，估值约为 1998 万美元。该交易已向美国证券交易委员会（SEC）披露。该股东最近的交易包括以 19.80 美元购买 12,470 股、以 19.89 美元购买 15,100 股，以及以 19.54 美元购买 30,884 股。SRZN 股票保持在 20.00 美元，市值为 1.714 亿美元，市盈率为-0.90。分析师对该股票的评级不一，普遍目标价为 32.00 美元</p>

<p>Surrozen, Inc. (NASDAQ:SRZN - Get Free Report) major shareholder Group Gp Lp Column III acquired 5,523 shares of the business's stock in a transaction that occurred on Wednesday, January 14th. The shares were purchased at an average cost of $19.99 per share, for a total transaction of $110,404.77. Following the completion of the transaction, the insider directly owned 999,429 shares in the company, valued at $19,978,585.71. The trade was a 0.56% increase in their position. The purchase was disclosed in a legal filing with the Securities &amp; Exchange Commission, which is available through this hyperlink. Large shareholders that own more than 10% of a company's shares are required to disclose their sales and purchases with the SEC.</p>
<div class="lb-trans"><p>Surrozen, Inc.（纳斯达克代码：SRZN - 获取免费报告）主要股东 Group Gp Lp Column III 于 1 月 14 日星期三收购了 5,523 股该公司的股票。每股平均购买价格为 19.99 美元，总交易额为 110,404.77 美元。交易完成后，该内部人士直接持有公司 999,429 股股票，价值 19,978,585.71 美元。此次交易使其持股增加了 0.56%。该购买在向证券交易委员会的法律文件中披露，相关信息可通过此链接获取。持有公司超过 10% 股份的大股东需向 SEC 披露其买卖情况。</p>
</div><p>Group Gp Lp Column III also recently made the following trade(s):</p>
<div class="lb-trans"><p>Group Gp Lp Column III 最近还进行了以下交易：</p>
</div><ul>
<li>On Tuesday, January 13th, Group Gp Lp Column III bought 12,470 shares of Surrozen stock. The stock was purchased at an average cost of $19.80 per share, with a total value of $246,906.00.</li>
<li>On Tuesday, January 6th, Group Gp Lp Column III bought 15,100 shares of Surrozen stock. The stock was purchased at an average price of $19.89 per share, for a total transaction of $300,339.00.</li>
<li>On Friday, December 5th, Group Gp Lp Column III purchased 30,884 shares of Surrozen stock. The shares were purchased at an average price of $19.54 per share, for a total transaction of $603,473.36.</li>
<li>On Thursday, December 4th, Group Gp Lp Column III purchased 5,266 shares of Surrozen stock. The shares were purchased at an average cost of $17.35 per share, with a total value of $91,365.10.</li>
<li>On Thursday, November 13th, Group Gp Lp Column III acquired 315,457 shares of Surrozen stock. The stock was purchased at an average price of $12.65 per share, with a total value of $3,990,531.05.</li>
</ul>
<div class="lb-trans"><ul>
<li>在 1 月 13 日星期二，Group Gp Lp Column III 购买了 12,470 股 Surrozen 股票。每股平均购买价格为 19.80 美元，总价值为 246,906.00 美元。</li>
<li>在 1 月 6 日星期二，Group Gp Lp Column III 购买了 15,100 股 Surrozen 股票。每股平均价格为 19.89 美元，总交易额为 300,339.00 美元。</li>
<li>在 12 月 5 日星期五，Group Gp Lp Column III 购买了 30,884 股 Surrozen 股票。每股平均价格为 19.54 美元，总交易额为 603,473.36 美元。</li>
<li>在 12 月 4 日星期四，Group Gp Lp Column III 购买了 5,266 股 Surrozen 股票。每股平均购买价格为 17.35 美元，总价值为 91,365.10 美元。</li>
<li>在 11 月 13 日星期四，Group Gp Lp Column III 收购了 315,457 股 Surrozen 股票。每股平均价格为 12.65 美元，总价值为 3,990,531.05 美元。</li>
</ul>
</div><h2>Surrozen Stock Performance</h2>
<div class="lb-trans"><h2>Surrozen 股票表现</h2>
</div><p>SRZN stock remained flat at $20.00 during midday trading on Thursday. The company had a trading volume of 28,721 shares, compared to its average volume of 83,852. The business has a 50 day simple moving average of $18.38 and a 200-day simple moving average of $13.80. Surrozen, Inc. has a fifty-two week low of $5.90 and a fifty-two week high of $24.94. The stock has a market capitalization of $171.40 million, a P/E ratio of -0.90 and a beta of 0.58.</p>
<div class="lb-trans"><p>SRZN 股票在星期四的午盘交易中保持在 20.00 美元。该公司的交易量为 28,721 股，而其平均交易量为 83,852 股。该公司的 50 日简单移动平均线为 18.38 美元，200 日简单移动平均线为 13.80 美元。Surrozen, Inc.的 52 周最低价为 5.90 美元，52 周最高价为 24.94 美元。该股票的市值为 1.714 亿美元，市盈率为-0.90，贝塔值为 0.58。</p>
</div><p>Surrozen (NASDAQ:SRZN - Get Free Report) last posted its earnings results on Friday, November 7th. The company reported ($3.61) EPS for the quarter, missing analysts' consensus estimates of ($1.17) by ($2.44). The business had revenue of $0.98 million during the quarter. Surrozen had a negative return on equity of 4,055.04% and a negative net margin of 2,909.10%. On average, equities analysts predict that Surrozen, Inc. will post -8.49 earnings per share for the current year.</p>
<div class="lb-trans"><p>Surrozen（纳斯达克代码：SRZN - 获取免费报告）最近于 11 月 7 日星期五发布了其财报。该公司报告本季度每股收益为（3.61 美元），低于分析师一致预期的（1.17 美元），差距为（2.44 美元）。该季度的收入为 98 万美元。Surrozen 的股本回报率为-4,055.04%，净利润率为-2,909.10%。分析师平均预测 Surrozen, Inc.在本年度的每股收益为-8.49 美元。</p>
</div><h2>Analysts Set New Price Targets</h2>
<div class="lb-trans"><h2>分析师设定新目标价</h2>
</div><p>Several research firms have issued reports on SRZN. Lifesci Capital upgraded shares of Surrozen to a &#34;strong-buy&#34; rating in a research note on Thursday, November 13th. Weiss Ratings reissued a &#34;sell (d-)&#34; rating on shares of Surrozen in a report on Wednesday, October 8th. Finally, Wall Street Zen upgraded shares of Surrozen to a &#34;sell&#34; rating in a research report on Friday, November 28th. One investment analyst has rated the stock with a Strong Buy rating, one has issued a Buy rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of &#34;Moderate Buy&#34; and a consensus price target of $32.00.</p>
<div class="lb-trans"><p>几家研究公司对 SRZN 发布了报告。Lifesci Capital 在 11 月 13 日的研究报告中将 Surrozen 的股票评级上调至 “强力买入”。Weiss Ratings 在 10 月 8 日的报告中重新发布了 Surrozen 的 “卖出（d-）” 评级。最后，Wall Street Zen 在 11 月 28 日的研究报告中将 Surrozen 的股票评级上调至 “卖出”。一位投资分析师给予该股票 “强力买入” 评级，一位给予 “买入” 评级，一位给予 “卖出” 评级。根据 MarketBeat.com 的数据，该公司目前的平均评级为 “适度买入”，共识目标价为 32.00 美元。</p>
</div><p><strong>View Our Latest Analysis on SRZN</strong></p>
<div class="lb-trans"><p><strong>查看我们对 SRZN 的最新分析</strong></p>
</div><h2>Institutional Investors Weigh In On Surrozen</h2>
<div class="lb-trans"><h2>机构投资者对 Surrozen 的看法</h2>
</div><p>Hedge funds and other institutional investors have recently made changes to their positions in the business. Braidwell LP bought a new position in shares of Surrozen in the 2nd quarter worth approximately $1,252,000. Stempoint Capital LP increased its holdings in Surrozen by 185.1% during the second quarter. Stempoint Capital LP now owns 686,539 shares of the company's stock valued at $6,138,000 after buying an additional 445,713 shares during the last quarter. Stonepine Capital Management LLC increased its holdings in Surrozen by 7.1% during the second quarter. Stonepine Capital Management LLC now owns 306,029 shares of the company's stock valued at $2,736,000 after buying an additional 20,247 shares during the last quarter. Vanguard Group Inc. raised its position in Surrozen by 21.7% in the third quarter. Vanguard Group Inc. now owns 266,418 shares of the company's stock worth $3,433,000 after acquiring an additional 47,468 shares during the period. Finally, Acuta Capital Partners LLC boosted its stake in shares of Surrozen by 5.0% during the 3rd quarter. Acuta Capital Partners LLC now owns 178,415 shares of the company's stock worth $2,299,000 after acquiring an additional 8,415 shares during the last quarter. Hedge funds and other institutional investors own 66.57% of the company's stock.</p>
<div class="lb-trans"><p>对冲基金和其他机构投资者最近对该公司的持仓进行了调整。Braidwell LP 在第二季度购买了 Surrozen 的新头寸，价值约为 1,252,000 美元。Stempoint Capital LP 在第二季度将其在 Surrozen 的持股增加了 185.1%。Stempoint Capital LP 现在拥有 686,539 股该公司股票，价值 6,138,000 美元，此前在上个季度又购买了 445,713 股。Stonepine Capital Management LLC 在第二季度将其在 Surrozen 的持股增加了 7.1%。Stonepine Capital Management LLC 现在拥有 306,029 股该公司股票，价值 2,736,000 美元，此前在上个季度又购买了 20,247 股。Vanguard Group Inc.在第三季度将其在 Surrozen 的持仓增加了 21.7%。Vanguard Group Inc.现在拥有 266,418 股该公司股票，价值 3,433,000 美元，此前在该期间又收购了 47,468 股。最后，Acuta Capital Partners LLC 在第三季度将其在 Surrozen 的持股增加了 5.0%。Acuta Capital Partners LLC 现在拥有 178,415 股该公司股票，价值 2,299,000 美元，此前在上个季度又收购了 8,415 股。对冲基金和其他机构投资者持有该公司 66.57% 的股份。</p>
</div><h2>Surrozen Company Profile</h2>
<div class="lb-trans"><h2>Surrozen 公司简介</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>（获取免费报告）</p>
</div><p>Surrozen, Inc is a clinical-stage biopharmaceutical company focused on developing novel therapeutic antibodies that target the Wnt signaling pathway for applications in tissue repair, regeneration and oncology. Founded in 2012 and headquartered in South San Francisco, California, the company leverages its proprietary SurroBody platform to design bispecific antibody molecules capable of modulating Wnt receptor activity with enhanced tissue specificity.</p>
<div class="lb-trans"><p>Surrozen, Inc 是一家临床阶段的生物制药公司，专注于开发针对 Wnt 信号通路的新型治疗性抗体，应用于组织修复、再生和肿瘤学。该公司成立于 2012 年，总部位于加利福尼亚州南旧金山，利用其专有的 SurroBody 平台设计双特异性抗体分子，能够调节 Wnt 受体活性，具有增强的组织特异性。</p>
</div><p>The SurroBody platform enables the generation of high-affinity, dual-binding antibodies engineered to either activate or inhibit Wnt signaling, a pathway critical to cell proliferation, differentiation and homeostasis.</p>
<div class="lb-trans"><p>SurroBody 平台能够生成高亲和力、双结合抗体，这些抗体经过工程设计，能够激活或抑制 Wnt 信号通路，而该通路对细胞增殖、分化和稳态至关重要。</p>
</div><h2>Further Reading</h2>
<div class="lb-trans"><h2>进一步阅读</h2>
</div><ul>
<li>Five stocks we like better than Surrozen</li>
<li>Elon Taking SpaceX Public! $100 Pre-IPO Opportunity!</li>
<li>How a Family Trust May Be Able To Help Preserve Your Wealth</li>
<li>A U.S. “birthright” claim worth trillions - activated quietly</li>
<li>Executive Order 14330: Trump’s Biggest Yet</li>
<li>The Crash Has Already Started (Most Just Don’t See It Yet)</li>
</ul>
<div class="lb-trans"><ul>
<li>我们更看好的五只股票比 Surrozen 更好</li>
<li>Elon 将 SpaceX 上市！$100 的首次公开募股机会！</li>
<li>家族信托如何帮助保护您的财富</li>
<li>一项价值数万亿的美国 “出生权” 索赔 - 静悄悄地激活</li>
<li>执行命令 14330：特朗普最大的一次</li>
<li>崩盘已经开始（大多数人只是还没看到）</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/InsiderTradesChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9U1JaTg" alt="" original-src="https://www.marketbeat.com/scripts/InsiderTradesChart.ashx?Prefix=NASDAQ&amp;Symbol=SRZN"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，旨在为读者提供最快的报道和公正的覆盖。请将有关此故事的任何问题或评论发送至 contact@marketbeat.com.</em></p>
</div><h2>Should You Invest $1,000 in Surrozen Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1,000 美元在 Surrozen 吗？</h2>
</div><p>Before you consider Surrozen, you'll want to hear this.</p>
<div class="lb-trans"><p>在考虑 Surrozen 之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Surrozen wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只股票，顶级分析师正在悄悄地向客户推荐在更广泛的市场注意到之前购买……而 Surrozen 并不在名单上。</p>
</div><p>While Surrozen currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然 Surrozen 目前在分析师中获得了中等买入评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

Surrozen (NASDAQ:SRZN) 的主要股东购买了价值 110,404.77 美元的股票